Five-aminolevulinic acid: New approach for congenital sideroblastic anemia

Pediatr Int. 2018 May;60(5):496-497. doi: 10.1111/ped.13558.

Authors

Hiroyuki Ishida^{1

2}, Toshihiko Imamura³, Akira Morimoto^{3

4}, Tohru Fujiwara⁵, Hideo Harigae⁵

Affiliations

¹ Department of Pediatrics, Kyoto City Hospital, Kyoto, Japan.
² Department of Pediatrics, Matsushita Memorial Hospital, Moriguchi, Japan.
³ Department of Pediatrics, Kyoto Prefectural University of Medicine, Kyoto, Japan.
⁴ Department of Pediatrics, Jichi Medical University, Shimotsuke, Japan.
⁵ Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan.

PMID: 29878633
DOI: 10.1111/ped.13558

No abstract available

Keywords: 5-aminolevulinate synthase 2; 5-aminolevulinic acid; congenital sideroblastic anemia; pharmacokinetics.

Publication types

Case Reports

MeSH terms

Aminolevulinic Acid / therapeutic use*
Anemia, Sideroblastic / congenital
Anemia, Sideroblastic / diagnosis
Anemia, Sideroblastic / drug therapy*
Hematinics / therapeutic use*
Humans
Male
Young Adult

Substances

Hematinics
Aminolevulinic Acid